Mireille Sanders
Chief Operating Officer bij PHARMING GROUP N.V.
Vermogen: 879 337 $ op 31-03-2024
Profiel
Mireille Sanders is currently the Chief Operations Officer at Pharming Group NV.
Previously, she worked at Janssen Pharmaceuticals, Inc. as the Head-Clinical Supply Chain Strategic from 2016 to 2019.
Ms. Sanders is a graduate of Technische Universiteit Eindhoven.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PHARMING GROUP NV
0.12% | 31-03-2024 | 799 020 ( 0.12% ) | 879 337 $ | 31-03-2024 |
Actieve functies van Mireille Sanders
Bedrijven | Functie | Begin |
---|---|---|
PHARMING GROUP N.V. | Chief Operating Officer | 15-12-2020 |
Eerdere bekende functies van Mireille Sanders
Bedrijven | Functie | Einde |
---|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Mireille Sanders
Technische Universiteit Eindhoven | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PHARMING GROUP N.V. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |